Novel pyridine-containing azacrownethers for the chelation of therapeutic bismuth radioisotopes: Complexation study, radiolabeling, serum stability and biodistribution

Nucl Med Biol. 2018 May:60:1-10. doi: 10.1016/j.nucmedbio.2018.01.005. Epub 2018 Feb 6.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aza Compounds / chemistry*
  • Bismuth / therapeutic use*
  • Cattle
  • Drug Stability
  • Ethers / chemistry*
  • Female
  • Isotope Labeling
  • Mice
  • Models, Molecular
  • Molecular Conformation
  • Pyridines / blood
  • Pyridines / chemistry*
  • Pyridines / pharmacokinetics*
  • Pyridines / therapeutic use
  • Radioisotopes / therapeutic use*
  • Tissue Distribution

Substances

  • Aza Compounds
  • Bismuth-213
  • Ethers
  • Pyridines
  • Radioisotopes
  • pyridine
  • Bismuth